ruxolitinib
novartis,incyte
['mpnsm', 'comfort-i,(-comfort-ii)', 'rux,(-crux),(-trux),(-deruxtecan)', '#mpn', 'rux,(-crux),(-trux)', 'ruxolitinib']
explore the post hoc analysis of the comfort-i and -ii phase iii trials investigating ruxolitinib for the treatment of mf, recently published at #eha2023. #mpnsm #mpn 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm